McNeil

McNeil CONSUMER PRODUCTS COMPANY, CAMP HILL ROAD, FORT WASHINGTON, PA 19034, (215) 233-7000

October 8, 1982

Dear Doctor:

Because you are the best source patients have for accurate information about the continued use of TYLENOL® products, we would like to update you on our actions and recommendations.

The Food and Drug Administration has thoroughly investigated the McNeil Consumer Products Company manufacturing plants and has concluded that the contamination of Extra-Strength TYLENOL capsules did not occur in our facilities and that our manufacturing processes are consistent with the standards required.

Having withdrawn all TYLENOL capsule products from the market, McNeil is proceeding aggressively with the development of new tamper-resistant packaging for all of our products. In the meantime, TYLENOL tablets, both Extra-Strength and Regular Strength, remain an effective therapeutic alternative for your patients. The Commissioner of the Food and Drug Administration has stated that TYLENOL tablets could not have been tampered with in the same manner as capsules.

Finally, enclosed is a public service announcement by the Commissioner of the Food and Drug Administration. In this statement, Dr. Hayes summarizes the sense of stock experienced by all of us regarding the recent situation. He also notes that effective measures are being taken to help ensure that nothing like this happens again.

McNeil Consumer Products Company appreciates the support of the health care profession and will do everything possible to continue to justify your trust and confidence in our products.

Sincerely,
Thomas N. Gates, M.D.
Medical Director
McNeil Consumer Products Company